based enzyme substrates onto microarray platforms and used
them to profile substrate specificities of proteases.4 Since
coumarin dyes are excited in the UV region (maximum λex
∼350 nm), these strategies have not been effective due to
high fluorescence backgrounds and the lack of microarray
scanners with UV light sources. For similar reasons, cou-
marin-based peptide substrates are rarely used in live-cell
imaging experiments.1b
quinone and the nonfluorescent spirolactone forms of R110
reduces fluorescence output.7b,c Our new fluorophore, Sin-
gapore Green (SG), is a hybrid of R110 and the fluorescein
analogue 2-Me TokyoGreen (Figure 1),8 with a phenolic
group on one end providing a chemical handle (for solid-
phase peptide synthesis, microarray immobilization, and
potentially other applications in cell-based experiments) and
an amino group on the other end serving as the point of
conjugation to a peptide sequence. We reasoned that ami-
dation at the amino group of SG by a peptide should suppress
the fluorescence of the dye. Similar fluorescence-quenching
effects have been observed in other coumarin- and rhodamine-
based peptide conjugates.5 Cleavage of the amide bond by
a protease should release the highly fluorescent SG, thus
reporting protease activity accordingly. Herein, we report the
synthesis and characterizations of SG, the solid-phase
synthesis of SG-conjugated peptides, as well as their
applications in microarray-based and live-cell imaging ex-
periments.
Figure 1. Structures of common fluorophores used in fluorogenic
peptide substrates (ACC and Rhodamine 110) and fluorophores
from which Singapore Green was derived (Rhodamine 110 and
Tokyo Green).
We sought to replace coumarin with a new fluorophore
having excitation and emission wavelengths in the visible
range, so that it is suitable for both microarray and live-cell
imaging applications. We turned to other fluorescein and
rhodamine fluorophores that have been used for labeling
reagents and enzymatic assays.5 Of these, Rhodamine 110
(R110)-based substrates are well-established peptide probes
for serine and cysteine proteases.6,7 Despite the desirable
fluorescence properties of R110, several drawbacks hinder
the direct use of these substrates: (1) R110-conjugated
peptides require both peptide groups to be cleaved in order
to generate maximum fluorescence and thus are not suitable
for quantitative studies of linear enzyme kinetics;5,6a (2)
“asymmetric” versions of these dyes containing a single
peptide cleavage site lack an immobilization handle which
is essential for both solid-phase peptide synthesis and
microarray applications;7b-d (3) equilibrium between the
Figure 2. (A) Fluorescence spectra of SG1. Fluorescence increase
from cleavage of Ac-DEVD-SG1 by caspase-3 (blue line) and
caspase-7 (red line) over the background fluorescence (orange line).
As shown in Scheme 1, the synthesis of SG started with
the formation of the asymmetric xanthone 1, which was
generated by Ullman-type coupling between 3-acetami-
dophenol and 2-chloro-4-nitrobenzoic acid based on a
published procedure.9 Diazotization of the amino group and
hydrolysis of the diazonium salt yields the phenol 2 which
underwent methylation or alkylation with a linker unit to
give 3. The nitro group was subsequently reduced to give
4a and 4b. Subsequent trityl protection and Grignard addition
of o-tolylmagnesium bromide followed by deprotection of
the trityl group afforded the fluorophores SG1 and SG2,
respectively. SG1 was found to have excitation maxima at
469 and 493 nm and emission maxima at 517 nm in ethanol
(Figure 2a), similar to fluorescein (494 and 521 nm respec-
tively, in water), and is thus compatible with the 488 nm
argon-ion laser used in most microarray scanners and
fluorescence microscopes. SG1 has a quantum yield of 0.50
and an extinction coefficient of 28500 M-1cm-1, which is
(4) (a) Zhu, Q.; Uttamchandani, M.; Li, D.; Lesaicherre, M. L.; Yao,
S. Q. Org. Lett. 2003, 5, 1257–1260. (b) Salisbury, C. M.; Maly, D. J.;
Ellman, J. A. J. Am. Chem. Soc. 2002, 124, 14868–14870.
(5) (a) Sun, W. C.; Gee, K. R.; Klaubert, D. H.; Haugland, R. P. J.
Org. Chem. 1997, 62, 6469–6475. (b) Mottram, L. F.; Boonyarattanakalin,
S.; Kovel, R. E.; Peterson, B. R. Org. Lett. 2006, 8, 581–584. (c) Mottram,
L. F.; Maddox, E.; Schwab, M.; Beaufils, F.; Peterson, B. R. Org. Lett.
2007, 9, 3741–3744.
(6) (a) Leytus, S. P.; Melhado, L. L.; Mangel, W. F Biochem. J. 1983,
209, 299–307. (b) Leytus, S. P.; Patterson, W. L.; Mangel, W. F Biochem.
J. 1983, 215, 253–260
.
(7) (a) Hug, H.; Los, M.; Hirt, W.; Debatin, K.-M. Biochemistry 1999,
38, 13906–13911. (b) Cai, S. X.; Zhang, H.-Z.; Guastella, J.; Drewe, J.;
Yang, W.; Weber, E. Bioorg. Med. Chem. Lett. 2001, 11, 39–42. (c) Zhang,
H.-Z.; Kasibhatla, S.; Guastella, J.; Tseng, B.; Drewe, J.; Cai, S. X.
Bioconjugate Chem. 2003, 14, 458–463. (d) Wang, Z.-Q.; Liao, J.; Diwu,
(8) Urano, Y.; Kamiya, M.; Kanda, K.; Ueno, T.; Hirose, K.; Nagano,
T. J. Am. Chem. Soc. 2005, 1274, 4888–4894.
(9) Ahn, Y.-H.; Lee, J. -S.; Chang, Y.-T. J. Am. Chem. Soc. 2007, 129,
4510–4511.
Z. Bioorg. Med. Chem. Lett. 2005, 15, 2335–2338
.
406
Org. Lett., Vol. 11, No. 2, 2009